L Chen

618 total citations
9 papers, 492 citations indexed

About

L Chen is a scholar working on Molecular Biology, Rheumatology and Genetics. According to data from OpenAlex, L Chen has authored 9 papers receiving a total of 492 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Rheumatology and 4 papers in Genetics. Recurrent topics in L Chen's work include Virus-based gene therapy research (4 papers), Immunotherapy and Immune Responses (3 papers) and Spondyloarthritis Studies and Treatments (3 papers). L Chen is often cited by papers focused on Virus-based gene therapy research (4 papers), Immunotherapy and Immune Responses (3 papers) and Spondyloarthritis Studies and Treatments (3 papers). L Chen collaborates with scholars based in United States, United Kingdom and Belgium. L Chen's co-authors include D Chen, Donald Küfe, Yoshinobu Manome, Howard A. Fine, Michael A. O’Donnell, Edward R. Block, Steven K. Clinton, Paul Bowness, Yaa‐Hui Dong and Toshihide Tanaka and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Immunology and Annals of the Rheumatic Diseases.

In The Last Decade

L Chen

9 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Chen United States 7 224 221 186 169 62 9 492
William Swaney United States 10 278 1.2× 227 1.0× 119 0.6× 212 1.3× 21 0.3× 18 534
Hannelien Verbeke Belgium 9 188 0.8× 126 0.6× 36 0.2× 234 1.4× 23 0.4× 9 424
William K. Witmer United States 7 187 0.8× 136 0.6× 105 0.6× 339 2.0× 15 0.2× 7 635
Shantha Senadheera United States 11 206 0.9× 279 1.3× 150 0.8× 203 1.2× 21 0.3× 18 621
Nanette Mittereder United States 6 93 0.4× 177 0.8× 157 0.8× 48 0.3× 40 0.6× 8 371
Xingwen Dong United States 9 224 1.0× 266 1.2× 69 0.4× 83 0.5× 72 1.2× 15 528
Arash Radfar United States 12 72 0.3× 174 0.8× 26 0.1× 228 1.3× 23 0.4× 25 377
Lars T. van der Veken Netherlands 13 311 1.4× 175 0.8× 274 1.5× 311 1.8× 132 2.1× 25 731
Kenichi Shimane Japan 10 233 1.0× 89 0.4× 85 0.5× 52 0.3× 173 2.8× 18 467
Judy Browning Australia 15 678 3.0× 392 1.8× 49 0.3× 429 2.5× 12 0.2× 18 925

Countries citing papers authored by L Chen

Since Specialization
Citations

This map shows the geographic impact of L Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Chen more than expected).

Fields of papers citing papers by L Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Chen. The network helps show where L Chen may publish in the future.

Co-authorship network of co-authors of L Chen

This figure shows the co-authorship network connecting the top 25 collaborators of L Chen. A scholar is included among the top collaborators of L Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Chen. L Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Li, Yuxue, et al.. (2024). Silencing of lncRNA NEAT1 alleviates acute myocardial infarction by suppressing miR-450–5p/ACSL4-mediated ferroptosis. Experimental Cell Research. 442(2). 114217–114217. 8 indexed citations
2.
Chen, L, et al.. (2017). Is Behçet's disease a ‘class 1-opathy’? The role of HLA-B*51 in the pathogenesis of Behçet's disease. Clinical & Experimental Immunology. 191(1). 11–18. 50 indexed citations
3.
Strand, Vibeke, Kurt de Vlam, Gladman Dd, et al.. (2017). AB0794 Effect of tofacitinib on patient-reported outcomes in patients with active psoriatic arthritis: results from two phase 3 studies. Annals of the Rheumatic Diseases. 76. 1335–1336. 1 indexed citations
4.
Chen, L, Hussein Al‐Mossawi, Anne J. Ridley, et al.. (2016). miR-10b-5p is a novel Th17 regulator present in Th17 cells from ankylosing spondylitis. Annals of the Rheumatic Diseases. 76(3). 620–624. 60 indexed citations
5.
Hammitzsch, Ariane, L Chen, Hussein Al‐Mossawi, et al.. (2016). OP0156 Deciphering The in Vitro Therapeutic Potential of JAK Inhibitors in Ankylosing Spondylitis. Annals of the Rheumatic Diseases. 75. 115–115. 1 indexed citations
6.
Gong, Jianlin, L Chen, D Chen, et al.. (1997). Induction of antigen-specific antitumor immunity with adenovirus-transduced dendritic cells. Gene Therapy. 4(10). 1023–1028. 97 indexed citations
8.
Chen, L, Michael A. Pulsipher, D Chen, et al.. (1996). Selective transgene expression for detection and elimination of contaminating carcinoma cells in hematopoietic stem cell sources.. Journal of Clinical Investigation. 98(11). 2539–2548. 56 indexed citations
9.
Chen, L, D Chen, Yoshinobu Manome, et al.. (1995). Breast cancer selective gene expression and therapy mediated by recombinant adenoviruses containing the DF3/MUC1 promoter.. Journal of Clinical Investigation. 96(6). 2775–2782. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026